Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Blood Disorders Clinical Trial
Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2
Status: Enrolling
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Infertility Clinical Trial
Eeva™ Pregnancy Pilot Study (PPS)
Status: Enrolling
Updated: 10/19/2015
mi
from
Boston, MA
Click here to add this to my saved trials
Healthy Clinical Trial
Investigating the Effects of Nutrition on the Maturation of Brain Networks Associated With Memory in Infants
Status: Enrolling
Updated: 12/3/2015
mi
from
Urbana, IL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Mitochondrial Function in Patients With Severe Liver Disease
Status: Enrolling
Updated: 3/21/2018
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Blinatumomab in Patients With B-cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Psychiatry / Psychology, Orthopedics / Podiatry, Other Clinical Trial
Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
The Diabetes Medication Adherence Promotion Intervention Trial
Status: Enrolling
Updated: 1/25/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Effects of High Flow Nasal Cannula on Deadspace Reduction and Regional Distribution of Ventilation
Status: Enrolling
Updated: 10/25/2017
mi
from
Seattle, WA
Click here to add this to my saved trials
Clinical Trial
Endotracheal Tube Audible Leak Test
Status: Enrolling
Updated: 10/16/2015
mi
from
Jackson, MS
Click here to add this to my saved trials
Non-Alcoholic Fatty Liver Disease Clinical Trial
Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth
Status: Enrolling
Updated: 12/8/2015
mi
from
Atlanta, GA
Click here to add this to my saved trials
Fertility Clinical Trial
Measuring Core Body Temperature Using TempuRing
Status: Enrolling
Updated: 4/5/2017
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroenterology, Pulmonary / Respiratory Diseases Clinical Trial
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Rochester, MN
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Treatment of Type 2 Diabetes With Immunonutrients
Status: Enrolling, Phase I
Updated: 7/27/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD
Status: Enrolling, Phase II
Updated: 3/29/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Mobile Health (mHealth) Black Women With Breast Cancer
Status: Enrolling
Updated: 7/26/2016
mi
from
Gainesville, FL
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Larynx Clinical Trial
HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
Status: Enrolling, Phase II
Updated: 10/11/2017
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
Status: Enrolling, Phase II
Updated: 10/11/2017
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Back Pain Clinical Trial
Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools
Status: Enrolling
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Pensacola, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology, Ophthalmology, Pulmonary / Respiratory Diseases Clinical Trial
Early Non Invasive Ventilation and Hematological Malignancies
Status: Enrolling
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Mesothelioma Clinical Trial
Intrapleural Cryotherapy for Malignant Pleural Mesothelioma
Status: Enrolling
Updated: 12/31/1969
mi
from
Rochester, MN
Click here to add this to my saved trials
Clinical Trial
Supplemental Oxygen Study
Status: Enrolling
Updated: 6/4/2015
mi
from
Long Beach, CA
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Charleston, SC
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
West Allis, WI
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Venous Thromboembolism Clinical Trial
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Wilmington, DE
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jackson, MS
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Diego, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aberdeen, SD
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Allentown, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anderson, SC
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Antigo, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bardstown, KY
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bellevue, WA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Billings, MT
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boulder, CO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Brainerd, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Branson, MO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bremerton, WA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bryan, TX
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burien, WA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, IL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Centerville, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chardon, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Charlotte, NC
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clackamas, OR
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cody, WY
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbia, MO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, GA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Coos Bay, OR
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Crown Point, IN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Delaware, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Des Moines, IA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Des Moines, IA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Duluth, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Easton, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Effingham, IL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Emeryville, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Englewood, CO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Englewood, CO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ephrata, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Evanston, IL
Click here to add this to my saved trials